Literature DB >> 15744088

Pharmacokinetics of chitobiose and chitotriose administered intravenously or orally to rats.

An-Shu Chen1, Tadao Taguchi, Hirokazu Okamoto, Kazumi Danjo, Kazuo Sakai, Yoshiharu Matahira, Min-Wei Wang, Ichitomo Miwa.   

Abstract

Chitooligosaccharides have attracted much attention as new biomedical materials. The biologic availability of each of these chitooligosaccharides, however, has not yet been studied. In the present study, we found that chitobiose and chitotriose appeared in the blood of rats with maximum plasma concentrations at around 1 h after administration when given orally at a dose of 30 mg/kg. However, chitotetraose and chitopentaose did not appear in the blood when given at a dose of 300 mg/kg. Pharmacokinetic analysis of chitobiose and chitotriose after intravenous administration at 100 mg/kg revealed that both sugars were eliminated from the body following a one-compartment model and that the former relative to the latter was higher for both the total body clearance (224+/-43 vs. 155+/-26 ml/h/kg) and the distribution volume (107+/-15 vs. 65+/-9 ml/kg). The absolute oral bioavailability of chitobiose was higher than that of chitotriose at all doses (30, 100, and 300 mg/kg) examined. The first-order absorption rate constants for chitobiose and chitotriose at all doses were less than 1.0 h(-1) and smaller than the elimination rate constants (2.2+/-0.3, 2.7+/-0.1 h(-1), respectively). The absorption was slow, resulting in flip-flop kinetics. This study indicates that among various chitooligosaccharides, only chitobiose and chitotriose can be appreciably absorbed from the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15744088     DOI: 10.1248/bpb.28.545

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

Review 1.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

2.  Chitin degradation potential and whole-genome sequence of Streptomyces diastaticus strain CS1801.

Authors:  Tiantian Xu; Manting Qi; Haiying Liu; Dan Cao; Chenlei Xu; Limei Wang; Bin Qi
Journal:  AMB Express       Date:  2020-02-08       Impact factor: 3.298

3.  Novel Chitohexaose Analog Protects Young and Aged mice from CLP Induced Polymicrobial Sepsis.

Authors:  Pragnya Das; Santosh K Panda; Beamon Agarwal; Sumita Behera; Syed M Ali; Mark E Pulse; Joseph S Solomkin; Steven M Opal; Vineet Bhandari; Suchismita Acharya
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

4.  Chitotriosidase Activity Is Counterproductive in a Mouse Model of Systemic Candidiasis.

Authors:  Nicholas A Schmitz; Ritesh P Thakare; Chun-Shiang Chung; Chang-Min Lee; Jack A Elias; Chun Geun Lee; Brian W LeBlanc
Journal:  Front Immunol       Date:  2021-03-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.